Neuromuscular complications of critical illness are common, and can be severe and
persistent, with substantial impairment in physical function and long-term quality of life …

Neuromuscular complications of critical illness are common and can be severe and
persistent in some patients. Neuromyopathy from critical illness and disuse atrophy from …

Critically ill patients often acquire neuropathy and/or myopathy labeled ICU-acquired
weakness. The current insights into incidence, pathophysiology, diagnostic tools, risk …

Neuromuscular disorders in the background of critical illness are under diagnosed.
Standardized screening for weakness in the intensive care unit (ICU) setting is uncommon …

Background Muscular weakness and/or muscle wasting is recognized as a key medical
problem in critically ill patients on intensive care units (ICUs) worldwide. Methods and …

Observational studies of patients receiving prolonged mechanical ventilation and other
forms of critical care support have determined acquired neuromuscular disorders to be …

Intensive care unit–acquired weakness (ICU-AW) is the most common neuromuscular
impairment in critically ill patients. We discuss critical aspects of ICU-AW that have not been …

ICU-acquired weakness (ICUAW) occurs with reported incidence rates from 25% to 100%.
Risk factors include immobility, sepsis, persistent systemic inflammation, multiorgan system …

Muscular weakness and atrophy in intensive care patients has long been attributed to a
combination of immobilization and cataboly. More recently, it has become apparent that …

Neuromuscular dysfunction is prevalent in critically ill patients, is associated with worse
short-term outcomes, and is a determinant of long-term disability in intensive care unit …